How CHR protects patients in the time of COVID-19: March 2020 CHR VOICE

The March issue of the CHR VOICE is running a few days late because we knew that we had to address the CORONA virus and how CHR is responding to the public health crisis to protect the safety of our patients, staff and everyone in the community. But whenever we set down to write the article, new developments occurred, CDC advice changed and/or other public statements from different organizations had to be considered. As of this moment, March 12, 2020, when these pages are being finalized, what you will be reading represents CHR’s most up-to-date understanding of what the current situation is and requires. Possibly, maybe even likely, by the time you will be reading these pages, this information may already be outdated. We, therefore, can only advise you to remain informed through news media and official government announcements on city, state and federal levels.

In this issue of the CHR VOICE, we cover:

• CHR's response to the coronavirus outbreak (Published 3/13/2020, with links to further updates)
  • Does COVID-19 have an effect on fertility?
  • What happens if I get quarantined during an IVF cycle?
  • What happens if CHR is closed for quarantine during my IVF cycle?
  • What should fertility patients do during the coronavirus outbreak?
  • Should international patients of IVF do anything differently during the outbreak?
• Three PRP studies for ovarian function at CHR

Norbert Gleicher, MD, FACOG, FACS

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.

Follow on LinkedIn    

Watch his videos on YouTube    

We have helped women bring over
17,800 babies into the world.

DISCOVER YOUR TREATMENT OPTIONS